Immunitybio Inc. Earnings

Immunitybio Inc.’s revenue jumped 425.07% since last year same period to $32.06Mn in the Q3 2025. On a quarterly growth basis, Immunitybio Inc. has generated 21.33% jump in its revenue since last 3-months.

Immunitybio Inc.’s net profit jumped 21.55% since last year same period to $-67.25Mn in the Q3 2025. On a quarterly growth basis, Immunitybio Inc. has generated 27.34% jump in its net profits since last 3-months.

Immunitybio Inc.’s net profit margin jumped 85.06% since last year same period to -209.77% in the Q3 2025. On a quarterly growth basis, Immunitybio Inc. has generated 40.11% jump in its net profit margins since last 3-months.

Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.08 - a 31.92% jump from last quarter’s estimates.

Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.08.

Immunitybio Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Immunitybio Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.